Amitava Chakrabarti

1.9k total citations
79 papers, 1.3k citations indexed

About

Amitava Chakrabarti is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Amitava Chakrabarti has authored 79 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cellular and Molecular Neuroscience, 15 papers in Molecular Biology and 14 papers in Pharmacology. Recurrent topics in Amitava Chakrabarti's work include Neuroscience and Neuropharmacology Research (21 papers), Epilepsy research and treatment (11 papers) and Drug Transport and Resistance Mechanisms (8 papers). Amitava Chakrabarti is often cited by papers focused on Neuroscience and Neuropharmacology Research (21 papers), Epilepsy research and treatment (11 papers) and Drug Transport and Resistance Mechanisms (8 papers). Amitava Chakrabarti collaborates with scholars based in India, United Kingdom and United States. Amitava Chakrabarti's co-authors include Debasish Hota, Lekha Saha, Pinaki Dutta, Anil Bhansali, Alka Bhatia, Dibyajyoti Banerjee, Dipika Bansal, Bikash Medhi, Bhattacharya Sk and Anand Srinivasan and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Amitava Chakrabarti

77 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amitava Chakrabarti India 23 347 260 199 172 171 79 1.3k
Anjali Rao India 20 200 0.6× 421 1.6× 191 1.0× 107 0.6× 158 0.9× 72 1.8k
Mahmoud M. Khattab Egypt 26 374 1.1× 499 1.9× 202 1.0× 92 0.5× 188 1.1× 88 2.0k
Gerardo Reyes-Garcı́a Mexico 20 432 1.2× 168 0.6× 109 0.5× 172 1.0× 196 1.1× 77 984
Daniela Cerretani Italy 25 216 0.6× 417 1.6× 132 0.7× 94 0.5× 190 1.1× 62 1.9k
Atilla İlhan Türkiye 21 248 0.7× 303 1.2× 105 0.5× 45 0.3× 108 0.6× 45 1.7k
G. Pinardi Chile 27 797 2.3× 316 1.2× 389 2.0× 152 0.9× 309 1.8× 64 1.7k
Larissa Constantino Brazil 25 209 0.6× 369 1.4× 220 1.1× 175 1.0× 155 0.9× 57 1.7k
Francisco Javier Flores‐Murrieta Mexico 23 494 1.4× 341 1.3× 266 1.3× 73 0.4× 408 2.4× 115 1.6k
Bart Marescau Belgium 32 623 1.8× 566 2.2× 298 1.5× 177 1.0× 120 0.7× 80 2.5k
Takeyoshi Sata Japan 25 453 1.3× 485 1.9× 401 2.0× 102 0.6× 113 0.7× 120 1.9k

Countries citing papers authored by Amitava Chakrabarti

Since Specialization
Citations

This map shows the geographic impact of Amitava Chakrabarti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amitava Chakrabarti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amitava Chakrabarti more than expected).

Fields of papers citing papers by Amitava Chakrabarti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amitava Chakrabarti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amitava Chakrabarti. The network helps show where Amitava Chakrabarti may publish in the future.

Co-authorship network of co-authors of Amitava Chakrabarti

This figure shows the co-authorship network connecting the top 25 collaborators of Amitava Chakrabarti. A scholar is included among the top collaborators of Amitava Chakrabarti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amitava Chakrabarti. Amitava Chakrabarti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chakrabarti, Amitava, Yelena Drexler, James P. Lash, et al.. (2025). Life's Essential 8, Cardiovascular Health, and CKD Progression among Hispanic/Latino Adults: The Hispanic Community Health Study/Study of Latinos Study. Clinical Journal of the American Society of Nephrology. 20(4). 502–511.
2.
Joshi, Rupa, et al.. (2024). SEW2871 reduces seizures via the sphingosine 1‐phosphate receptor‐1 pathway in the pentylenetetrazol and phenobarbitone kindling model of drug‐refractory epilepsy. Clinical and Experimental Pharmacology and Physiology. 51(3). e13839–e13839. 2 indexed citations
3.
4.
Prakash, Ajay, Praveen Kumar, Phulen Sarma, et al.. (2021). Neuroprotective Effect of Celastrus Paniculatus Seed Extract on Epilepsy and Epilepsy-associated Cognitive Deficits. Basic and Clinical Neuroscience Journal. 14(1). 155–166. 1 indexed citations
5.
Gamad, Nanda, Pradip Kumar Saha, Prashant Sharma, et al.. (2021). A randomized controlled trial comparing the efficacy, tolerability, and cost of oral iron preparations in iron‐deficiency anemia in pregnancy. Journal of obstetrics and gynaecology research. 47(11). 3828–3841. 7 indexed citations
7.
Chakrabarti, Amitava. (2016). MALDI-TOF. International Journal of Infectious Diseases. 45. 26–26. 1 indexed citations
9.
Mukherjee, P., et al.. (2014). STUDY OF HAEMATOLOGICAL PROFILES OF DOGS INFECTED WITH PATHOGENIC AEROBES. SHILAP Revista de lepidopterología. 2 indexed citations
10.
11.
Mittal, Rakesh, Niti Mittal, Debasish Hota, et al.. (2014). Antioxidant effect of isoflavones: A randomized, double-blind, placebo controlled study in oophorectomized women. International Journal of Applied and Basic Medical Research. 4(1). 28–28. 6 indexed citations
12.
Saha, Lekha & Amitava Chakrabarti. (2014). Understanding the anti-kindling role and its mechanism of Resveratrol in Pentylenetetrazole induced-kindling in a rat model. Pharmacology Biochemistry and Behavior. 120. 57–64. 36 indexed citations
13.
Srinivasan, Anand, Kirtimaan Syal, Dibyajyoti Banerjee, et al.. (2013). Low plasma levels of cholecalciferol and 13-cis-retinoic acid in tuberculosis: Implications in host-based chemotherapy. Nutrition. 29(10). 1245–1251. 16 indexed citations
14.
Singh, Pawan Kumar, Debasish Hota, Pinaki Dutta, et al.. (2012). Pantoprazole Improves Glycemic Control in Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial. The Journal of Clinical Endocrinology & Metabolism. 97(11). E2105–E2108. 48 indexed citations
15.
Chakrabarti, Amitava, et al.. (2005). A note on generalized demodicosis in canines. The Indian Veterinary Journal. 82(7). 794–794. 2 indexed citations
16.
Chakrabarti, Amitava, et al.. (1998). Dose-Finding Study with Nimodipine: A Selective Central Nervous System Calcium Channel Blocker on Aminophylline Induced Seizure Models in Rats. Brain Research Bulletin. 45(5). 495–499. 23 indexed citations
17.
Garg, S K, et al.. (1991). Comparative bioavailability and in-vitro antimicrobial activity of two different brands of rifampicin. European Journal of Drug Metabolism and Pharmacokinetics. 16(3). 223–229. 5 indexed citations
18.
Nayak, Niranjan, et al.. (1990). An outbreak of inclusion body hepatitis in broiler chickens in West Bengal.. The Indian Veterinary Journal. 67(1). 7–9. 1 indexed citations
19.
Chattopadhyay, Dipankar, et al.. (1980). An unusual association ofTrichophyton mentagrophytesandDemodex canisin a mongrel dog with multiple kerions. Annals of Tropical Medicine and Parasitology. 74(1). 101–102.
20.
Chakrabarti, Amitava, et al.. (1974). Osteomalacia, myopathy and basilar impression. Journal of the Neurological Sciences. 23(2). 227–235. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026